Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

11.50
Delayed Data
As of Mar 05
 -0.04 / -0.35%
Today’s Change
3.44
Today|||52-Week Range
11.98
+22.47%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 14.50, with a high estimate of 20.00 and a low estimate of 12.00. The median estimate represents a +26.09% increase from the last price of 11.50.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Pernix Therapeutics Holdings Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.14
Sales
$49.0M
Reporting Date
May 18

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 30.00%
 
 
 
 
 
 
Growthannually 49.19%
 
 
 
 
 
 

Sales

Growthquarterly -9.00%
 
 
 
 
 
 
Growthannually 81.87%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account